Add to a list

Inactive Instrument

Carmat Stock Other OTC

FR0010907956

Medical Equipment, Supplies & Distribution

OTC Markets Traded

Analysts' recommendations: Carmat

25-05-09	Carmat: Invest Securities raises target price
25-04-11	Carmat: Invest Securities still a buyer, but cuts TP
25-02-04	Carmat: Invest Securities slightly lowers its target
25-01-09	Carmat: Invest Securities upgrades to buy
25-01-09	Carmat: Oddo BHF reduces its price target

More recommendations

News in other languages: Carmat

Mar. 04	Carmat, Ynsect… quand les pépites industrielles françaises tombent dans le gouffre de Moore
Jan. 07	Pluxee N : Carmat, Hoffmann, LDC, Pluxee, Technip Energies... les valeurs à suivre aujourd'hui à Paris
Jan. 07	Bourse : GTT et Technip Energy engrangent, Pluxee publie, Carmat disparaît
Jan. 07	CARMAT : A suivre aujourd'hui
Jan. 07	Les records continuent à tomber en bourse

More news

Managers and Directors: Carmat

Manager	Title	Age	Since
Stéphane Piat CEO	Chief Executive Officer	55	2016-08-31
Pascale d’Arbonneau DFI	Director of Finance/CFO	-	2018-12-11
Christian Latrémouille CTO	Chief Tech/Sci/R&D Officer	-	2025-03-31

Director	Title	Age	Since
Stéphane Piat BRD	Director/Board Member	55	-
Jean-Luc Lemercier BRD	Director/Board Member	68	2017-01-01
Michael Mack BRD	Director/Board Member	79	2017-04-19

More insiders

Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

As early as today, start finding the best investment opportunities!

Maximize my profits

Market Cap	6.15M 6.99M 5.72M 5.25M 9.87M 670M 10M 68M 26.56M 331M 26.24M 25.68M 1.14B	P/E 2023	-3.09x	P/E 2024	-0.95x
Enterprise Value	59.25M 67.39M 55.15M 50.65M 95.11M 6.46B 96.36M 656M 256M 3.19B 253M 248M 11.03B	EV / Sales 2023	56.1x	EV / Sales 2024	13.5x
Free-Float	89.06%	Yield 2023 *	-	Yield 2024	-

Jan. 07	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris
Jan. 07	CARMAT: To Watch Today
Jan. 06	Carmat, GTT, Genfit, LDC... Stocks to Watch Tomorrow in Paris
Jan. 06	Carmat Announces Liquidation and Delisting
Dec. 02	Only Takeover Bid for Carmat Approved by Court
Dec. 02	Carmat: Takeover Offer Approved, 88 Jobs Saved	RE
Dec. 02	Carmat receives takeover bid	RE
Nov. 04	Carmat SAS submits bid for Carmat SA within ongoing receivership procedure	RE
25-10-15	CAC 40 Surges on LVMH Results and Easing US-China Tensions
25-10-15	Carmat: Judicial Recovery Continues, New Hearing Set for November 25	RE
25-10-15	Carmat says liquidation review postponed until Nov 25	RE
25-10-01	Carmat: Judicial Liquidation Request to Be Reviewed on October 14	RE
25-10-01	Carmat: Judiciary administrator has submitted request to convert receivership into liquidation to court	RE

Dec. 02	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
Nov. 04	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
25-10-29	CARMAT : Inside Information / Other news releases	PU
25-10-29	CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)	BU
25-10-15	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARMAT	-.--%	-.--%	-	-	7.08M
STRYKER CORPORATION	+1.97%	+5.51%	-16.55%	+19.41%	129B
SMITH & NEPHEW PLC	+1.93%	+2.11%	-0.98%	-2.80%	13.01B
GLAUKOS CORPORATION	-1.09%	-2.28%	+61.09%	+95.26%	8.92B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+5.94%	+2.18%	-45.47%	-69.36%	4.65B
AXONICS, INC.	+0.75%	-.--%	-.--%	+33.92%	3.63B
DOUBLE MEDICAL TECHNOLOGY INC.	+2.16%	-1.57%	+0.47%	+40.11%	2.68B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+1.49%	-2.72%	-19.16%	-26.12%	1.61B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	+3.09%	-0.25%	-25.21%	-33.80%	1.63B
ENOVIS CORPORATION	+4.51%	+5.25%	+2.58%	-55.84%	1.63B
Average	+2.08%	+1.41%	-4.80%	+0.09%	18.54B
Weighted average by Cap.	+1.92%	+2.73%	-11.28%	+18.21%

	2023	2024
Net sales	3.84M 4.36M 3.57M 3.28M 6.16M 419M 6.24M 42.46M 16.58M 207M 16.38M 16.03M 714M	7.34M 8.35M 6.84M 6.28M 11.79M 801M 11.94M 81.26M 31.74M 396M 31.36M 30.68M 1.37B
Net income	-53.87M -61.28M -50.15M -46.05M -86.47M -5.88B -87.61M -596M -233M -2.9B -230M -225M -10.03B	-51.4M -58.46M -47.84M -43.94M -82.5M -5.61B -83.59M -569M -222M -2.77B -219M -215M -9.57B
Net Debt	49.64M 56.46M 46.2M 42.43M 79.68M 5.41B 80.73M 549M 215M 2.67B 212M 207M 9.24B	53.1M 60.4M 49.43M 45.39M 85.24M 5.79B 86.36M 588M 229M 2.86B 227M 222M 9.89B

Carmat Stock Other OTC

Stocks

FR0010907956

Medical Equipment, Supplies & Distribution

Valuation: Carmat

Latest news : Carmat

Analysts' recommendations: Carmat

Press Releases: Carmat

News in other languages: Carmat

Managers and Directors: Carmat

Medical Devices & Implants

Financials

Company Profile